Results 71 to 80 of about 22,497,798 (252)

Association of statin use and increase in lipoprotein(a): a real-world database research

open access: yesEuropean Journal of Medical Research, 2023
Background There is an increased concern that statins may have an unintended effect of elevated lipoprotein(a) [Lp(a)]. We conducted a large sample real-world study to test the association. Methods This retrospective cohort study was conducted using data
Tienan Feng   +17 more
doaj   +1 more source

Gain-pisua eta hipertentsioa duten pertsonetan jarduera fisiko aerobiko-programa baten osteko efektuak odol-presioaren aldakortasunean [PDF]

open access: yes, 2018
Lan honen helburu nagusia gain-pisua eta hipertentsioa duten pertsonetan jarduera fisiko aerobiko-programaren efektuak odol-presioaren aldakortasunean nola eragiten duten aztertzea da. Horretaz gain, jarduera fisiko aerobiko programa ezberdinen efektuak,
Berastegi Razkin, Iraitz
core  

The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis

open access: yesEuropean Journal of Medical Research, 2022
Background Lipoprotein(a) [Lp(a)] is one of the residual risk factors for cardiovascular disease (CVD) in the setting of optimal low-density lipoprotein cholesterol (LDL-C).
Shiyue Wang   +9 more
doaj   +1 more source

Risco Cardiovascular em Doentes com Infecção por Vírus da Imunodeficiência Humana [PDF]

open access: yes, 2010
O aumento do risco cardiovascular é considerada uma importante complicação da infecção Infecção por Vírus da Imunodeficiência Humana (VIH) e da terapêutica anti-retroviral (TARV).
Mansinho, K   +3 more
core  

Estudio de la actividad de la lipoproteina lipasa en pacientes con mutaciones APOA5 con hiperlipoproteinemia tipo I [PDF]

open access: yes, 2019
Nuestro objetivo fue estudiar la actividad de la lipoproteína lipasa en pacientes con mutaciones en APOA5 con presencia clara de hiperlipoproteinemia tipo I (HPLI).
Sánchez Tévar, Ana María
core  

Serum Fas/FasL levels in dependence on clinical presentations of coronary disease and their relationship with risk factors [PDF]

open access: yes, 2010
Background/Aim. Ischemic heart disease is mostly a consequence of atherosclerosis. Besides the inflammation, the Fas/Fas ligand (FasL)/caspase death pathway is documented to be activated in atherosclerotic lesions.
Deljanin-Ilić Marina   +4 more
core   +1 more source

Aumento de catecolaminas como posible causa de resistencia a la insulina en pacientes con síndrome de apnea-hipopnea obstructiva de sueño [PDF]

open access: yes, 2012
La resistencia a insulina en pacientes SAHS podría estar vehiculizada por el incremento de actividad simpática secundaria a los fenómenos de apnea-hipopnea.
Bravo Portolés, Isabel   +4 more
core  

Klasterska analiza [PDF]

open access: yes, 2016
U ovom radu opisana je klasterska analiza te njena primjena na bazu dijabetičara podijeljenih prema stupnju bolesti. Klasterska analiza podrazumijeva grupiranje jedinki u klastere tako da su jedinke unutar klastera ”najsličnije”.
Ungaro, Tea
core   +2 more sources

Influence of parenteral application of beta-carotene on fertility in cows [PDF]

open access: yes, 2008
Thirty Holstein breed cows from the breeding stock of high yielding dairy cattle were selected for testing. The cows were selected during their high gravidity and fell into two groups. The i.m beta-carotene, Carofertin, of 20 ml (200 mg of beta-carotene)
Veličković Miljan, Vuković Dragan
core   +1 more source

Evaluación de un método rápido para la detección de niveles elevados de lipoproteína (a): AubioDOT Lp (a). Evaluation of a fast method for the detection of elevated levels of lipoprotein (a): AuBioDOT Lp(a).

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 1998
La lipoproteína (a) [Lp (a)] ha sido identificada como un factor de riesgo independiente de enfermedad vascular ateroesclerótica (arterio-coronaria,cerebrovascular y vascular periférica), por lo que su determinación ha cobrado gran interés en los últimos
Maritza B. Torres   +4 more
doaj  

Home - About - Disclaimer - Privacy